The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein
Authors
Keywords
-
Journal
PROTEIN ENGINEERING DESIGN & SELECTION
Volume 23, Issue 11, Pages 827-834
Publisher
Oxford University Press (OUP)
Online
2010-09-04
DOI
10.1093/protein/gzq058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bispecific Antibodies for Cancer Immunotherapy
- (2010) Dafne Müller et al. BIODRUGS
- Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen
- (2010) Claudia Bluemel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
- (2010) Takuo Suzuki et al. JOURNAL OF IMMUNOLOGY
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon
- (2010) A. Walker et al. PROTEIN ENGINEERING DESIGN & SELECTION
- New Strategy for the Extension of the Serum Half-Life of Antibody Fragments
- (2009) Sabrina Trüssel et al. BIOCONJUGATE CHEMISTRY
- Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
- (2009) Roland E. Kontermann BIODRUGS
- Next generation immunotherapeutics—honing the magic bullet
- (2009) Carrie Enever et al. CURRENT OPINION IN BIOTECHNOLOGY
- The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics
- (2009) Jan Terje Andersen et al. Drug Metabolism and Pharmacokinetics
- Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding
- (2009) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives
- (2009) Roland Stork et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- N-Glycosylation as Novel Strategy to Improve Pharmacokinetic Properties of Bispecific Single-chain Diabodies
- (2008) Roland Stork et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Murine endoglin-specific single-chain Fv fragments for the analysis of vascular targeting strategies in mice
- (2008) Dafne Müller et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Engineering of a femtomolar affinity binding protein to human serum albumin
- (2008) A. Jonsson et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin
- (2002) Martin Linhult et al. PROTEIN SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started